Euroapi announces that its Board of Directors has approved an investment of 40 million euros to implement a new vitamin B12 production technology at its Saint-Aubin-lès-Elbeuf site in the Seine-Maritime region.

This project should enable the company to increase its production capacity by 2025, while reducing its environmental footprint. The investment is backed by a total of €7.9 million in public funding.

The new-generation fermentation technology will increase the site's production by 60%, with a more robust, environmentally-friendly and simpler manufacturing process. Vitamin B12 production is expected to reach full capacity by 2027.

Copyright (c) 2023 CercleFinance.com. All rights reserved.